Emergent Biosolutions, Inc.Emergent Biosolutions, Inc.Emergent Biosolutions, Inc.

Emergent Biosolutions, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪258.87 M‬USD
‪−760.50 M‬USD
‪1.05 B‬USD
‪50.47 M‬
Beta (1Y)

About Emergent Biosolutions, Inc.

Joseph C. Papa
Employees (FY)
‪1.6 K‬
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EBS is 4.76 USD — it has decreased by 3.64% in the past 24 hours. Watch Emergent Biosolutions, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Emergent Biosolutions, Inc. stocks are traded under the ticker EBS.
EBS stock has fallen by 9.68% compared to the previous week, the month change is a 109.69% rise, over the last year Emergent Biosolutions, Inc. has showed a 43.20% decrease.
We've gathered analysts' opinions on Emergent Biosolutions, Inc. future price: according to them, EBS price has a max estimate of 5.00 USD and a min estimate of 5.00 USD. Watch EBS chart and read a more detailed Emergent Biosolutions, Inc. stock forecast: see what analysts think of Emergent Biosolutions, Inc. and suggest that you do with its stocks.
EBS reached its all-time high on Aug 6, 2020 with the price of 137.61 USD, and its all-time low was 1.42 USD and was reached on Feb 6, 2024. View more price dynamics on EBS chart.
See other stocks reaching their highest and lowest prices.
EBS stock is 9.03% volatile and has beta coefficient of 2.81. Track Emergent Biosolutions, Inc. stock price on the chart and check out the list of the most volatile stocks — is Emergent Biosolutions, Inc. there?
Today Emergent Biosolutions, Inc. has the market capitalization of ‪249.43 M‬, it has increased by 106.60% over the last week.
Yes, you can track Emergent Biosolutions, Inc. financials in yearly and quarterly reports right on TradingView.
Emergent Biosolutions, Inc. is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
EBS earnings for the last quarter are 0.59 USD per share, whereas the estimation was −0.98 USD resulting in a 160.20% surprise. The estimated earnings for the next quarter are −0.95 USD per share. See more details about Emergent Biosolutions, Inc. earnings.
Emergent Biosolutions, Inc. revenue for the last quarter amounts to ‪300.40 M‬ USD despite the estimated figure of ‪220.25 M‬ USD. In the next quarter revenue is expected to reach ‪190.00 M‬ USD.
EBS net income for the last quarter is ‪9.00 M‬ USD, while the quarter before that showed ‪−49.50 M‬ USD of net income which accounts for 118.18% change. Track more Emergent Biosolutions, Inc. financial stats to get the full picture.
No, EBS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 25, 2024, the company has ‪1.60 K‬ employees. See our rating of the largest employees — is Emergent Biosolutions, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Emergent Biosolutions, Inc. EBITDA is ‪128.70 M‬ USD, and current EBITDA margin is −4.09%. See more stats in Emergent Biosolutions, Inc. financial statements.
Like other stocks, EBS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Emergent Biosolutions, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Emergent Biosolutions, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Emergent Biosolutions, Inc. stock shows the sell signal. See more of Emergent Biosolutions, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.